Close
FINDING CURES TOGETHER<sup>SM</sup>

MEG Scholar-in-Training Award

Established in 2003 and funded by MEG membership dues, the MEG Award for Student Excellence in Molecular Epidemiology is awarded each year to three early-career scientists whose abstract accepted for presentation at the AACR Annual Meeting has been highly rated by the Program Committee. The purpose of the award is to highlight the work being done by talented early-career scientists and to promote the importance of the field to others who may be considering a career in the growing discipline of molecular epidemiology. Awardees are recognized at the MEG Town Meeting, and receive a complimentary year of membership in the Working Group.

To be considered for the MEG Award, associate members should indicate that they wish to be considered for a Scholar-in-Training Award when submitting an abstract in the online abstract submitter. All eligible candidates will automatically be considered.

MEG Scholar-in-Training Award Recipients for 2018

Xiaoliang (Wendy) WangXiaoliang (Wendy) Wang, PhD, MPH
Fred Hutchinson Cancer Research Center
Seattle, Washington
Functionally informed genome-wide interaction analysis of nonsteroidal anti-inflammatory drugs on colorectal cancer risk

Minisymposium MS.EP01.01 - Genetic and Molecular Epidemiology of Cancer Risk and Prognosis
Presentation #2965
McCormick Place Convention Center South (Level 5)
Room S505
Monday, April 16, 2018, 3:05 – 3:20 p.m.
Dr. Wang is currently a postdoctoral fellow in the Public Health Sciences Division at the Fred Hutchinson Cancer Research Center. She received a PhD in Epidemiology from the University of Washington in Seattle in 2017. Her research interest lies in exploring the gene-environmental interactions in colorectal and breast cancers using genomic, environmental and clinical data.

Jihye KimJihye Kim, PhD          
Harvard T.H. Chan School of Public Health
Boston, Massachusetts
Absolute risk prediction models for pancreatic cancer

Minisymposium MS.EP01.02. Endogenous and Exogenous Factors in Cancer Risk and Mortality
Presentation #4945
McCormick Place Convention Center South (Level 5)
Room S504
Tuesday, April 17, 2018, 4:05 – 4:20 p.m.
Dr. Kim is working as a postdoctoral fellow in the Department of Epidemiology at Harvard T.H. Chan School of Public Health. She received a PhD in epidemiology from the University of Texas School of Public Health at Houston in 2016. Her research interest is cancer risk prediction modeling with a wide range of risk factors such as lifestyles, comorbidity, biomarkers, metabolites, as well as genotype data. Her current project is focused on risk prediction models for pancreatic cancer to identify a subset of the general population at high risk of pancreatic cancer.

Lang WuLang Wu, PhD
Vanderbilt University School of Medicine
Nashville, Tennessee
Genetically predicted blood protein biomarkers and prostate cancer risk: an analysis in over 140,000 European descendants

Minisymposium MS.EP01.01. Genetic and Molecular Epidemiology of Cancer Risk and Prognosis
Presentation #2969
McCormick Place Convention Center South (Level 5)
Room S505
Monday, April 16, 2018, 4:05 – 4:20 p.m
Dr. Wu is a postdoctoral research fellow in the Division of Epidemiology at Vanderbilt University Medical Center. He received a BS in biological sciences from Wuhan University and a PhD in clinical and translational science from Mayo Clinic College of Medicine. Dr. Wu’s research interests are investigating genetic, environmental and lifestyle factors in cancer etiology and prognosis, with a goal of translating the gained knowledge for risk assessment, early detection, prevention, and prognosis prediction of human malignancies. Currently, he is focused on identifying novel cancer susceptibility genes and biomarkers through integrating genomics, transcriptomics, methylome, proteomics and metabolomics data, with an emphasis on prostate, pancreatic, and breast cancers.